ID and Testing Via Friendship Networks (NCT00841360) | Clinical Trial Compass
CompletedNot Applicable
ID and Testing Via Friendship Networks
United States535 participantsStarted 2009-01
Plain-language summary
This is a pilot study with a cross-sectional research design to recruit Hispanic/Latina and African American adolescent and young adult women, aged 13-24 years to serve as index recruiters, who will in turn recruit members of her female friendship network, aged 13 years and older to undergo HIV screening. This approach seeks to identify new HIV infections in the target population.
Who can participate
Age range
13 Years – 24 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for INDEX RECRUITERS:
* Born female;
* Aged 13-24 years at the time of consent;
* African American or Hispanic/Latina ethnicity or mixed-race/ethnicity, which must include African American race and/or Hispanic/Latina ethnicity;
* A history of sexual intercourse with at least one male sexual partner;
* Any HIV status as follows: (1) HIV positive; (2) HIV negative defined as receiving a negative HIV test result \< 12 months prior to the date of study consent); or (3) HIV status unknown defined as either no history of HIV testing or receipt of negative HIV test results more than 12 months prior to the date of study consent);
* History of vaginal and/or anal sexual intercourse with a male;
* Willing to complete a HIV risk assessment; and
* Willing to recruit two or more friendship network members to discuss and eventually undergo HIV screening;
* Ability to understand written and spoken English; and
* Willing to provide written informed consent/assent.
Inclusion Criteria for FRIENDSHIP NETWORK MEMBERS:
* Born female;
* Aged \> 13 years at the time of consent;
* A history of sexual intercourse with at least one male sexual partner;
* Willing to complete an HIV risk assessment;
* Willing to discuss and consider HIV screening;
* Self-report that the most recent HIV test result was negative, or has no prior history of HIV testing;
* Ability to understand written and spoken English; and
* Willing to provide written informed consent/assent.
Exclusion Criteria for…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of young women (HIV status positive, negative, or unknown) who are identified and recruited to serve as index recruiters divided by the number of young women screened.
Timeframe: 2
2
Proportion of index recruiters who recruit two or more of their female, friendship network members to undergo HIV screening.
Timeframe: 2 years
3
A description of factors that facilitate and hinder index recruiters in recruiting female friendship network members.
Timeframe: 2 years
4
A description of factors that facilitate and hinder HIV screening among female friendship network members.
Timeframe: 2 years
5
A preliminary estimate of HIV infection prevalence among the friendship networks of all index recruiters and separately in the friendship networks of each group of index recruiters.